Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genta to evaluate G-3139 in U.S. prostate cancer trial

Dec. 5, 1997

Fareston launched in U.S. for metastatic breast cancer

Dec. 4, 1997

Agouron, Roche terminate cancer collaboration; AG-337 development discontinued

Dec. 4, 1997

MDR modulators prepared at Janssen

Dec. 4, 1997

Single injections of RC-3095 produce prolonged reductions in EGF receptor number and expression

Dec. 4, 1997

Miravant reports promising interim phase III results for breast cancer trial

Dec. 4, 1997

Pfizer discontinues collaboration with Megabios

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Water-soluble taxanes reported in patent literature

Dec. 3, 1997

EntreMed reports positive preclinical results using Endostatin

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...